CB-103
CB-103 + lenvatinib or abemaciclib
Cellestia Biotech · Phase 1/2 · Recruiting · Enrollment 32
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
CB-103
Cellestia Biotech · Phase 1/2 · Recruiting · Enrollment 32
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.